Circulating Tumor Cells in Prostate Cancer Diagnosis and Monitoring: An Appraisal of Clinical Potential

被引：45

作者：

Galletti, Giuseppe ^{[1
,2
]}

Portella, Luigi ^{[1
,2
]}

Tagawa, Scott T. ^{[1
,2
]}

Kirby, Brian J. ^{[1
,2
,3
]}

Giannakakou, Paraskevi ^{[1
,2
]}

Nanus, David M. ^{[1
,2
]}

机构：

[1] Weill Cornell Med Coll, Div Hematol & Med Oncol, New York, NY 10021 USA

[2] Weill Cornell Med Coll, Weill Cornell Canc Ctr, New York, NY 10021 USA

[3] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA

来源：

MOLECULAR DIAGNOSIS & THERAPY | 2014年 / 18卷 / 04期

关键词：

MITOXANTRONE PLUS PREDNISONE; ANDROGEN RECEPTOR; PERIPHERAL-BLOOD; BREAST-CANCER; ANTITUMOR-ACTIVITY; INCREASED SURVIVAL; PREDICT SURVIVAL; END-POINTS; ANTIGEN; EXPRESSION;

D O I：

10.1007/s40291-014-0101-8

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Circulating tumor cells (CTCs) have emerged as a viable solution to the lack of tumor tissue availability for patients with a variety of solid tumors, including prostate cancer. Different approaches have been used to capture this tumor cell population and several of these techniques have been used to assess the potential role of CTCs as a biological marker to predict treatment efficacy and clinical outcome. CTCs are now considered a strong tool to understand the molecular characteristics of prostate cancer, and to be used and analyzed as a 'liquid biopsy' in the attempt to grasp the biological portrait of the disease in the individual patient.

引用

页码：389 / 402

页数：14

共 103 条

[1] Detection of circulating prostate-specific antigen-secreting cells in prostate cancer patients
Alix-Panabières, C
Rebillard, X
Brouillet, JP
Barbotte, E
Iborra, F
Segui, B
Maudelonde, T
Jolivet-Reynaud, C
Vendrell, JP
[J]. CLINICAL CHEMISTRY, 2005, 51 (08) : 1538 - 1541
[2] Characterization and enumeration of cells secreting tumor markers in the peripheral blood of breast cancer patients
Alix-Panabières, C
Brouillet, JP
Fabbro, M
Yssel, H
Rousset, T
Maudelonde, T
Choquet-Kastylevsky, G
Vendrell, JP
[J]. JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 299 (1-2) : 177 - 188
[3] Detection and characterization of putative metastatic precursor cells in cancer patients
Alix-Panabieres, Catherine
Vendrell, Jean-Pierre
Pelle, Olivier
Rebillard, Xavier
Riethdorf, Sabine
Mueller, Volkmar
Fabbro, Michel
Pantel, Klaus
[J]. CLINICAL CHEMISTRY, 2007, 53 (03) : 537 - 539
[4] Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer
Alix-Panabieres, Catherine
Vendrell, Jean-Pierre
Slijper, Monique
Pelle, Olivier
Barbotte, Eric
Mercier, Gregoire
Jacot, William
Fabbro, Michel
Pantel, Klaus
[J]. BREAST CANCER RESEARCH, 2009, 11 (03):
[5] Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases
Allard, WJ
Matera, J
Miller, MC
Repollet, M
Connelly, MC
Rao, C
Tibbe, AGJ
Uhr, JW
Terstappen, LWMM
[J]. CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6897 - 6904
[6] Anand A, 2010, ASCO ANN M
[7] Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, Gerald L.
Grubb, Robert L., III
Buys, Saundra S.
Chia, David
Church, Timothy R.
Fouad, Mona N.
Gelmann, Edward P.
Kvale, Paul A.
Reding, Douglas J.
Weissfeld, Joel L.
Yokochi, Lance A.
Crawford, E. David
O'Brien, Barbara
Clapp, Jonathan D.
Rathmell, Joshua M.
Riley, Thomas L.
Hayes, Richard B.
Kramer, Barnett S.
Izmirlian, Grant
Miller, Anthony B.
Pinsky, Paul F.
Prorok, Philip C.
Gohagan, John K.
Berg, Christine D.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (13) : 1310 - 1319
[8] [Anonymous], UROL ONCOL
[9] Antonarakis ES, 2013, ASCO ANN M
[10] Prostate-specific antigen and pain surrogacy analysis in metastatic hormone-refractory prostate cancer
Armstrong, Andrew J.
Garrett-Mayer, Elizabeth
Yang, Yi-Chun Ou
Carducci, Michael A.
Tannock, Ian
de Wit, Ronald
Eisenberger, Mario
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3965 - 3970

← 1 2 3 4 5 6 7 8 9 10 →